HEXO Corp (HEXO)
0.71
0.00 (0.00%)
USD |
NASDAQ |
Jun 30, 16:00
HEXO Net Income (Quarterly): -86.43M for April 30, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2023 | -86.43M |
| January 31, 2023 | 0.5354M |
| October 31, 2022 | -42.26M |
| July 31, 2022 | -77.98M |
| April 30, 2022 | -114.39M |
| January 31, 2022 | -560.98M |
| October 31, 2021 | -93.25M |
| July 31, 2021 | -56.16M |
| April 30, 2021 | -16.44M |
| January 31, 2021 | -16.19M |
| October 31, 2020 | -3.174M |
| July 31, 2020 | -123.24M |
| April 30, 2020 | -14.20M |
| January 31, 2020 | -226.54M |
| October 31, 2019 | -45.33M |
| July 31, 2019 | -33.67M |
| April 30, 2019 | -5.820M |
| January 31, 2019 | -3.246M |
| Date | Value |
|---|---|
| October 31, 2018 | -9.822M |
| July 31, 2018 | -8.055M |
| April 30, 2018 | -1.548M |
| January 31, 2018 | -7.076M |
| October 31, 2017 | -1.534M |
| July 31, 2017 | 0.707M |
| April 30, 2017 | -8.877M |
| January 31, 2017 | -0.8349M |
| December 31, 2016 | -0.0209M |
| September 30, 2016 | -0.0106M |
| June 30, 2016 | -0.0098M |
| March 31, 2016 | -0.0304M |
| December 31, 2015 | -0.0074M |
| September 30, 2015 | -0.0364M |
| June 30, 2015 | -0.0021M |
| March 31, 2015 | -0.0214M |
| December 31, 2014 | -0.1221M |
| June 30, 2014 | -0.0056M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-560.98M
Minimum
Jan 2022
0.5354M
Maximum
Jan 2023
-80.45M
Average
-42.26M
Median
Oct 2022
Net Income (Quarterly) Benchmarks
| Acasti Pharma Inc | -4.023M |
| Aurinia Pharmaceuticals Inc | -11.49M |
| Edesa Biotech Inc | -1.985M |
| Lexaria Bioscience Corp | -2.372M |
| Liminal Biosciences Inc | -6.795M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 15.92M |
| Total Expenses (Quarterly) | 35.88M |
| EPS Diluted (Quarterly) | -1.939 |
| Gross Profit Margin (Quarterly) | -43.34% |
| Profit Margin (Quarterly) | -543.0% |